Peer Review History: Nirmatrelvir-ritonavir for Treating COVID-19 Patients: A Case-Control Study

Editor(s):

(1) Prof. Ashish Anand, William Carey School of Osteopathic Medicine and University of Mississippi Medical Center, Mississippi, USA.

(2) Dr. Meng Ma, Anhui University, China.

Reviewers:

(1) Venkata Suresh Babu Agala, G H Raisoni University, India.

(2) Kaaviya. R, Sri Venkateshwaraa Medical College Hospital And Research Centre, India.

(3) Ali Faaeq Shaheed Samaraey, Imam Ja’afar Al-Sadiq University, Kirkuk, Iraq.

(4) Fariba Ghasemi, Islamic Azad University, Tehran, Iran.

Additional Reviewers:

Additional Reviewers: (Comments received after deadline)

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.25/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer Review Report_1 (Venkata Suresh Babu Agala, India) | File 1 | NA


Stage 2 | Peer Review Report_2 (Kaaviya. R, India) | File 1 | NA


Stage 2 | Peer Review Report_3 (Ali Faaeq Shaheed Samaraey, Iraq) | File 1 | NA


Stage 2 | Peer Review Report_4 (Fariba Ghasemi, Iran) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 4 | Comment_Editor_2_v1 | File 1 | NA


Posted in Review History.